Opportunity

Simpler Grants.gov #FOR-FD-25-017

FDA Grant Funding for Natural History Studies in Rare Diseases

Buyer

Food and Drug Administration

Posted

July 11, 2025

Identifier

FOR-FD-25-017

NAICS

541715

This opportunity from the Food and Drug Administration (FDA) invites applications for grant funding to support natural history studies in rare diseases or conditions with unmet medical needs. - Government Buyer: - Food and Drug Administration (FDA) - Purpose and Scope: - Grant funding for efficient and innovative natural history studies - Focus on generating high-quality, interpretable data to address knowledge gaps and facilitate medical product development for rare diseases - Eligibility: - Open to higher education institutions, nonprofits, for-profit organizations, government entities, tribal organizations, and foreign organizations - Funding Details: - Minimum award amount: $400,000 - No specified maximum award amount - No cost sharing or matching required - Products/Services Requested: - No specific OEMs, vendors, products, or part numbers are mentioned - This is a research grant, not a procurement of goods or commercial services - Unique Requirements: - Projects must address critical barriers in rare disease research and support product development - Emphasis on innovative study designs and data quality

Description

This notice of funding opportunity (NOFO) supports efficient and innovative natural history studies to advance medical product development in rare diseases or conditions with unmet needs. The goal is to generate high quality and interpretable data to address critical knowledge gaps, remove barriers in the field, and facilitate rare disease product development. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, for-profit organizations, government entities, and others. The minimum award amount is $400,000, with no specified maximum. The funding instrument type is a grant, and cost sharing or matching is not required.

View original listing